September 17, 2008

Safety And Effectiveness of Enteryx (REG) Procedure In Treating GERD Symptoms Part 3




Interim analysis grades at three months exhibit that, among the 62 patients (31 encircled by the ENTERYX Procedure mass and 31 in the point group) who be unspoken for all for evaluation, 50 percent of the ENTERYX group versus 23 percent of the control group (p<0.05) were competent to normalize or upgrade pH score. In the ENTERYX group, 83 percent of patients achieve victorious GERD-HRQL heartburn scores, defined in point of ≤11 or superlative from baseline via >9 spine, versus 54 percent of the control group (p<0.05). Mean metamorphose from baseline in pH-metry be -4.3 percent in the ENTERYX Procedure group vs. -0.5 percent in the control group (p<0.05).



But it's also likely that red grapefruit may envelop unknown chemical that are responsible for the observed triglyceride-lowering effect, she says. Additional study are studied.



Final results for the European-based be qualified, "ENTERYX for the nurture of GERD: 12-month follow-up results of a randomized, sham-controlled, multicenter trial" (Presentation # 324), presented by Jacques Devi�re, M.D., Professor of Medicine Chairman, Department of Gastroenterology and Hepatology, Erasme University Hospital, Universite Libre de Bruxelles, Brussels, Belgium and President-elect, European Society of Gastrointestinal Endoscopy associate PPI use for 32 patients who received an endoscopic immunisation of the ENTERYX Solution and 32 patients who undergo model endoscopy in a European multi-center trial of 64 patients. Results were identical close at hand those from prior open-label study of the ENTERYX Procedure and indicate that the feedback to the ENTERYX Procedure be not a placebo effect. After three months, 81 percent of patients undergo the ENTERYX Procedure and 53 percent of the control group have reduced their PPI use by at least impending 50 percent (p<0.05). Additionally, 68 percent of ENTERYX patients and 41 percent of control-group patients had completely eliminated PPIs (p<0.05). 81 percent of subject in the control group order the ENTERYX Procedure after they widely read that they were in the control group and were given the unpredictability for treatment. Follow-up with patients unbroken through 12 months after treatment. At 12 months, 70 percent of 20 ENTERYX patients were stationary previous its sell-by date PPIs.



Did you know? Best treat osteoporosis : quality, fast delivery, and super service on Qpills.net



Herpes treatment on buyzoviraxonline.com herpes testing



mens health - read about



No comments: